Connecta Therapeutics: Funding, Investors & Team (Oct 2026)
Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of the central nervous system. It focuses on the development of a first-in-class drug for the treatment of fragile X syndrome.
Connecta Therapeutics has raised $7.1M across 2 funding rounds on record, the most recent an undisclosed round of $4.2M announced in Sep 2026.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Connecta Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2026.
Connecta Therapeutics Funding Rounds
Connecta Therapeutics raised $2.9M in a Seed announced in Feb 2024.
2.6 years later, an undisclosed round of $4.2M was announced in Sep 2026.
Connecta Therapeutics Investors
10 investors are recorded in total; the 5 named above are those the record identifies.
Connecta Therapeutics Founders and Leadership Team
Contact details for the Connecta Therapeutics team: 1 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Connecta Therapeutics Funding Compared to Other Biotechnology Startups
Connecta Therapeutics' latest round of $4.2M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Connecta Therapeutics in Biotechnology and Barcelona
Companies Similar to Connecta Therapeutics
iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early…
Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological…
Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic…
IMPETUX develops and markets patented technology to characterise the mechanical properties of living tissues…
Molecular Gate refer to an innovative class of small-molecule drugs developed by Gate Bioscience. These drugs…
Modern medicine fails because it studies life in static environments. 60Nd revolutionizes the field with…
Devicare designs point-of-care medical devices that monitor, diagnose and treat chronic diseases. The…
Universal Diagnostics S.A. (UDX) is a company in Spain that specializes in in-vitro diagnostics. Their focus…
Phyture Biotech originated as a spin-off of the Faculty of Pharmacy at the University of Barcelona, founded…
Polimerbio offers sanitary product design and development based on biocompatible polymers, particularly…
Overture Life is a biotechnology company that specializes in developing automated technologies for assisted…
In order to cure diseases with unmet medical requirements, ARTHEx Biotech, a biotech business that was spun…
Connecta Therapeutics Funding FAQs
What does Connecta Therapeutics do?
Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of the central nervous system. It focuses on the development of a first-in-class drug for the treatment of fragile X syndrome.
How much funding has Connecta Therapeutics raised?
Connecta Therapeutics has raised $7.1M across 2 rounds on record. The most recent is an undisclosed round of $4.2M announced in Sep 2026.
When did Connecta Therapeutics last raise funding?
Connecta Therapeutics' most recent funding round on record is an undisclosed round of $4.2M, announced in Sep 2026.
Who has invested in Connecta Therapeutics?
Investors on record for Connecta Therapeutics include Inveready, Clave Capital, Centre for the Development of Industrial Technology (CDTI), ENISA, EIC Accelerator. FundedIQ records 10 investors in total.
Who founded Connecta Therapeutics?
FundedIQ lists Jordi Fabrega (Cofounder and CEO), Josep Prous (Founder) at Connecta Therapeutics.
Where is Connecta Therapeutics headquartered?
Connecta Therapeutics is based in Barcelona, Catalonia, Spain.
How many employees does Connecta Therapeutics have?
Connecta Therapeutics is in the 1-10 employee band.
When was Connecta Therapeutics founded?
Connecta Therapeutics was founded in 2019.
How does Connecta Therapeutics' funding compare to other Biotechnology startups?
Connecta Therapeutics' latest round of $4.2M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Connecta Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Connecta Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.